Mark Peek
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
Papers in
-
- Hemophilia Treatment and Research 4
- Blood Coagulation and Thrombosis Mechanisms 4
- Platelet Disorders and Treatments 2
-
- Liver physiology and pathology 4
- Co-authors
- Daniel Kirchhofer (8 shared papers)Paul Moran (7 shared papers)Michael T. Lipari (4 shared papers)Karen L. Billeci (2 shared papers)Charles Eigenbrot (4 shared papers)Bin Fan (1 shared paper)Robert A. Lazarus (3 shared papers)Dineli Wickramasinghe (1 shared paper)
- Journals
- Journal of Biological Chemistry (3 papers)Biochemistry (2 papers)Thrombosis and Haemostasis (1 paper)FEBS Letters (1 paper)Biochemical Journal (1 paper)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Mark Peek
9 papers receiving 426 citations
Peers
Comparison fields: 5 of 57
- Hepatology 189
- Hematology 105
- Genetics 65
- Immunology and Allergy 37
- Cancer Research 50
Countries citing papers authored by Mark Peek
This map shows the geographic impact of Mark Peek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Peek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Peek more than expected).
Fields of papers citing papers by Mark Peek
This network shows the impact of papers produced by Mark Peek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Peek. The network helps show where Mark Peek may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Peek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 129 | |
| 2 | 2003 | 88 | |
| 3 | 2004 | 78 | |
| 4 | 2002 | 59 | |
| 5 | 2000 | 33 | |
| 6 | 1999 | 20 | |
| 7 | 2004 | 19 | |
| 8 | 2017 | 17 | |
| 9 | 2002 | 13 |
About Mark Peek
Mark Peek is a scholar working on Hematology, Hepatology, Molecular Biology, Genetics and Computer Networks and Communications, having authored 9 papers that have together received 456 indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (4 papers), Liver physiology and pathology (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Platelet Disorders and Treatments (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Apelin-related biomedical research (1 paper) and Fibroblast Growth Factor Research (1 paper). The work is most often cited by research in Hepatology (189 citations), Hematology (105 citations), Genetics (65 citations), Immunology and Allergy (37 citations) and Cancer Research (50 citations). Mark Peek has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Daniel Kirchhofer, Paul Moran, Michael T. Lipari, Karen L. Billeci, Charles Eigenbrot, Bin Fan, Robert A. Lazarus, Dineli Wickramasinghe, Nerissa Mendoza and J. Michael Elliott. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry, Thrombosis and Haemostasis, FEBS Letters and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.